Ioannis Kyrou

Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation

Constantine Tsigos, Dimitris A. Papanicolaou, Ioannis Kyrou et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 317 citations · Full text

Inflammation, Metabolic Syndrome, Cytokine +13

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

Narjes Nasiri‐Ansari, Chrysa Nikolopoulou, Katerina Papoutsi et al. · International Journal of Molecular Sciences · 2021 · 278 citations · Full text

Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing’s Syndrome

Dimitris A. Papanicolaou, Nancy Mullen, Ioannis Kyrou et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 242 citations · Full text

Cushing ’, Screening Test, Stress Hormone +15

Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity

Constantine Tsigos, Ioannis Kyrou, Eftychia Chala et al. · Metabolism · 1999 · 233 citations

Obesity, Metabolic Syndrome, Inflammation +12

Dose Effects of Recombinant Human lnterleukin-6 on Pituitary Hormone Secretion and Energy Expenditure

Constantine Tsigos, Dimitris A. Papanicolaou, Ruby Defensor et al. · Neuroendocrinology · 1997 · 225 citations

Metabolic Rate, Dose Effects, Human Growth +21